Liquidity & Technical
Liquidity & Technical
Marex is institutionally tradable but size-aware: at 20% of average daily volume a fund clears roughly $64M of stock in five sessions, supporting a 5% portfolio weight for AUM up to about $1.28B. The tape stance is bullish but stretched — price closed today at an all-time high of $56.51, sits 47.7% above the 200-day moving average, just printed a fresh golden cross in late January, and is trading above its upper Bollinger band; the one feature that matters most is that this is a continuation breakout, not a reversal, but RSI at 68 and a negative MACD histogram say the chase has consequences.
1. Portfolio implementation verdict
5-day capacity at 20% ADV
Largest issuer position cleared in 5d (% mcap)
Supported fund AUM @ 5% weight (20% ADV)
ADV 20d / market cap (%)
Technical scorecard (-3 to +3)
Liquidity is fine; the tape setup is the constraint. A meaningful position is implementable for a multi-billion-dollar fund, but price is at all-time highs after a 6-month run of +85% and is stretched against every short-term volatility envelope. Add discipline, not size, is the issue.
2. Price snapshot
Current price (USD)
YTD return (%)
1-year return (%)
3-month return (%)
52-week position (%)
The 1-year number understates the move because the comparison base in May 2025 was already the prior cycle peak; the relevant figure is the 3-month return of 39.6%, accelerated by today's 8.9% session and the recent earnings catalyst.
3. Price + 50/200 SMA — full trading history
Most recent crossover: golden cross on 2026-01-23 (50d SMA recrossed above 200d SMA). A prior death cross on 2025-09-11 reflected the summer/early-autumn downdraft, which the November–April rebound has fully reversed.
Price is above the 200-day by 47.7% — this is an uptrend, full stop, and the moving averages are bullishly stacked (price > 20d > 50d > 100d > 200d). The history is short because Marex IPO'd in April 2024 at $18.99; the stock has tripled since.
4. Relative strength
Benchmark and sector ETF series were not retrieved in this run; the chart shows MRX-only trajectory. The standalone read is unambiguous: 100 at IPO → 297 today, roughly +198% over 24 months. Even if SPY tracked +15–20% over the same window, MRX has outperformed by an order of magnitude.
5. Momentum — RSI(14) + MACD histogram
RSI is at 68 — not yet overbought, but the second-highest reading in the past five months and rolling over from 75 in mid-April. The MACD histogram has flipped negative four sessions running (-0.24 today) even as price set a new high; that is a textbook momentum divergence and warns of a near-term cooling, not a trend break.
6. Volume, volatility, and sponsorship
The three highest volume-spike days were all to the upside in price terms, and recent activity through the May 6 earnings print (2.56M shares, more than 2× the 50-day average) carries the same signature: heavy turnover concentrated on positive prints. That is sponsorship, not distribution.
Realized vol sits at 46.9% — between the 50th percentile (33.6%) and the 80th percentile (54.0%) of the issuer's own two-year history. That is "elevated, not stressed," but the trajectory has been rising since early March alongside the rally; the market is paying for upside with a wider risk premium, which is consistent with breakout dynamics rather than capitulation.
7. Institutional liquidity panel
For a fund evaluating whether MRX absorbs real size: the answer is yes, with discipline.
A. ADV and turnover
ADV 20d (shares)
ADV 20d (USD value)
ADV 60d (shares)
ADV 20d / market cap (%)
Annual turnover (%)
Turnover of 326% is extraordinary for a recently-public name — the entire share count rotates roughly 3.3× per year. That is an actively-traded book, not a closely-held thinly-floated IPO.
B. Fund-capacity table
A $1.0B fund running 5% sleeves can implement MRX inside a week even at a conservative 10% participation rate. A $3.0B fund needs the more aggressive 20% rate to do the same. Above $5B AUM at a 5% weight, the position is no longer a one-week fill.
C. Liquidation runway
D. Execution friction
The 60-day median daily price range is 1.73%, which translates to elevated impact cost for blocks above 5% ADV — meaningful but not prohibitive. Above 2% would have flagged as costly; under 2% is normal for a small-mid-cap broker stock.
The largest issuer-level position that clears in five trading days is 1.0% of market cap (~$43M) at 20% ADV, or 0.5% (~$22M) at the more conservative 10% ADV. Beyond those thresholds, the trade becomes a multi-week build/exit, not a one-week one.
8. Technical scorecard and stance
Stance: tape is bullish but stretched on the 3-to-6 month horizon — patience bias on entry. Trend, sponsorship, and relative-strength scores collectively outweigh the volatility caution; a base-case path of continued grind higher with a 5–10% mean-reversion shake-out first is consistent with the setup. Above $60.00 — a sustained close above the round-number breakout extension — would confirm institutional follow-through; the next structural level is $66–70. Below $50.00 — the lower Bollinger band and recent breakout zone — invalidates the immediate breakout and re-targets the 50-day SMA at $45.20 (a structural test, not a trend break, until $38.30 / 200d gives way). Liquidity is not the constraint for funds up to roughly $1.3B running 5% sleeves; the constraint is entry timing — build over multiple weeks rather than chasing today's all-time-high print.